Variant report
Variant | nsv823149 |
---|---|
Chromosome Location | chr5:97256819-97296603 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CTD-2215E18.1.1-3 | chr5:97257835-97258399 | XLOC_004484 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187518307 | chr5:97256862-97256863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147654711 | chr5:97256871-97256872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs73156010 | chr5:97256885-97256886 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs115120781 | chr5:97256899-97256900 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192088039 | chr5:97256902-97256903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73156014 | chr5:97256922-97256923 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs569941844 | chr5:97256935-97256936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs142667171 | chr5:97256936-97256937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs550141660 | chr5:97256947-97256948 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs548664426 | chr5:97257043-97257044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184803551 | chr5:97257051-97257052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs17087915 | chr5:97257129-97257130 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs377524573 | chr5:97257146-97257147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553026559 | chr5:97257182-97257183 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150269122 | chr5:97257187-97257188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538828449 | chr5:97257252-97257253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569414856 | chr5:97257295-97257296 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557166993 | chr5:97257334-97257335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs189265762 | chr5:97257345-97257346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs180972229 | chr5:97257355-97257356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554621071 | chr5:97257360-97257361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs74541699 | chr5:97257856-97257857 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs570996476 | chr5:97257892-97257893 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs553812025 | chr5:97257903-97257904 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs371368552 | chr5:97257950-97257951 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs77613473 | chr5:97257961-97257962 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs367747435 | chr5:97258023-97258024 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs557105368 | chr5:97258032-97258033 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs569112333 | chr5:97258101-97258102 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs536503608 | chr5:97258120-97258121 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs545723034 | chr5:97258141-97258142 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs184198766 | chr5:97258162-97258163 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs111507581 | chr5:97258192-97258193 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs554501821 | chr5:97258219-97258220 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs540599017 | chr5:97258268-97258269 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs189855352 | chr5:97258277-97258278 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs577375735 | chr5:97258283-97258284 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs138602345 | chr5:97258299-97258300 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs563424427 | chr5:97258338-97258339 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs530718003 | chr5:97258347-97258348 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs542507128 | chr5:97258349-97258350 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs529739203 | chr5:97258352-97258353 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs528412603 | chr5:97258361-97258362 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs546542833 | chr5:97258398-97258399 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs192238982 | chr5:97259864-97259865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs541847628 | chr5:97259959-97259960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112876676 | chr5:97260041-97260042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs1423319 | chr5:97260047-97260048 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs527419710 | chr5:97260103-97260104 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs546388555 | chr5:97260132-97260133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:97256600-97257200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr5:97257000-97257400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:97259800-97260600 | Enhancers | GM12878-XiMat | blood |
4 | chr5:97264600-97265800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr5:97265200-97265800 | Enhancers | NHDF-Ad | bronchial |
6 | chr5:97265800-97271800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr5:97271800-97272200 | Enhancers | Adipose Nuclei | Adipose |
8 | chr5:97271800-97272200 | Enhancers | Brain Cingulate Gyrus | brain |
9 | chr5:97271800-97272200 | Enhancers | Fetal Lung | lung |
10 | chr5:97271800-97272400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr5:97271800-97272400 | Enhancers | Brain Substantia Nigra | brain |
12 | chr5:97271800-97272600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr5:97271800-97272800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr5:97272000-97272200 | Enhancers | NHDF-Ad | bronchial |
15 | chr5:97272000-97272400 | Enhancers | Brain Angular Gyrus | brain |
16 | chr5:97272000-97272800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr5:97273200-97274400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr5:97291400-97291600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |